TCIM
SER icon

TIAA CREF Investment Management’s Serina Therapeutics SER Stock Holding History

TIAA CREF Investment Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$120K Hold
845
– – ﹤0.01% 2947
2018
Q4 		$89K Buy
+845
New +$107K ﹤0.01% 2967

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Price Capital Management Lafayette, Louisiana $7.05M AUM 47.39% 1-Year Est. Return

TIAA CREF Investment Management's SER Position: Q1 2019 in Review

TIAA CREF Investment Management held its Serina Therapeutics (SER) position steady in Q1 2019 at 845 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

TIAA CREF Investment Management first reported a position in SER in Q4 2018 and has held it in 2 quarters since. 59 funds tracked by Wall St. Rank hold SER as of Q1 2019.

  • TIAA CREF Investment Management held 845 shares of Serina Therapeutics worth $120K as of Q1 2019.
  • TIAA CREF Investment Management left its Serina Therapeutics share count unchanged in Q1 2019.
  • Serina Therapeutics made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2947 holding.
  • TIAA CREF Investment Management first reported a position in Serina Therapeutics in Q4 2018 and has held it in 2 quarters since.
  • 59 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.